MEDEA Biopharma logo — Developing new generation of sustainable antibacterial solut...

MEDEA Biopharma

Developing new generation of sustainable antibacterial solutions.

Founded 2023 Germany Ludwigshafen, Germany 10 employees Seed

General Information

Company Name MEDEA Biopharma
Founded Year 2023
Location Germany Ludwigshafen, Germany +1
Employees 10
Funding Stage Seed
Social

Get notified when MEDEA Biopharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MEDEA Biopharma

MEDEA Biopharma is a forward-looking biotech company founded in 2023 in Ludwigshafen, Germany. The firm, driven by co-founders Rüdiger Trojok, Dr. Elene Kakabadze, and Giorgi Khubua, is at the forefront of addressing the global crisis of antimicrobial resistance. Their innovative approach utilizes bacteriophages, or phages, as sustainable solutions to replace conventional antibiotics.

Committed to environmental responsibility, MEDEA Biopharma's phage-based solutions are tailored to be highly specific, void of side effects, and applicable across multiple sectors, ranging from human health to agriculture. This aligns with their slogan of "Developing new generation of sustainable antibacterial solutions."

The company's recent recognition includes a Support Program investment from MassChallenge, marked on 01 May 2024. The investment underscores its potential for substantial impact and growth within the biotechnology sector and highlights its innovative approach to enduring challenges.

Taxonomy: sustainable antibacterial solutions, biotech innovation, antimicrobial resistance, bacteriophages, eco-friendly solutions, natural bacterial killers, alternative to antibiotics, human health, animal well-being, agriculture, phage therapy, biopharmaceuticals, environmentally responsible technology, biological pest control

Services & Products

Development of bacteriophage-based solutions
Animal therapeutic solutions
Nutraceutical ingredients for supplements

Target Customers

Healthcare providers dealing with antimicrobial resistance Animal health professionals Manufacturers of human and animal supplements

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Support Program •••••• 1
Investor
01 May 2024
Spinout •••••• 1 •••• •••• 01 Jan 2023

MEDEA Biopharma Alternatives & Competitors

View All Alternatives
MEDEA Biopharma vs
MEDEA
MEDEA United States

To provide governments, businesses, and organizations with the products they need.

51 employees
Health Care, Pharmaceutical
MEDEA Biopharma vs

At the forefront of the fight against antibioresistant bacteria

Grant
8 employees
Biotechnology, Health Care
MEDEA Biopharma vs

Pioneering all-natural and alternative solutions for pest control, aromatherapy, pain management, an...

Series Unknown
11-50 employees
Agriculture, Manufacturing

FAQ About MEDEA Biopharma

Developing new generation of sustainable antibacterial solutions.
MEDEA Biopharma was founded in 2023.
MEDEA Biopharma is headquartered in Ludwigshafen, Germany.
MEDEA Biopharma has approximately 10 employees.
MEDEA Biopharma has completed 2 funding rounds. The latest funding stage is Seed.
MEDEA Biopharma offers: Development of bacteriophage-based solutions, Animal therapeutic solutions, Nutraceutical ingredients for supplements.
Top alternatives and competitors to MEDEA Biopharma include MEDEA, Pherecydes Pharma, Med-X, DOCFLIQ, Scandinavian Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MEDEA Biopharma and MEDEA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MEDEA Biopharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy